logo-loader
RNS
Optima Health PLC

Notice of Half Year Results

RNS Number : 8518D
Optima Health PLC
19 November 2026
 

 

Optima Health plc

(“Optima”, the “Company”, and, together with its subsidiaries, the “Group”)

 

Notice of Half Year Results

 

LONDON, UK, 19 November 2026, Optima Health (AIM: OPT), the UK’s leading provider of technology enabled corporate health and wellbeing solutions, will announce its results for the six months ended 30 September 2026 on Tuesday 1 December 2026.

 

Jonathan Thomas, Chief Executive Officer and Andrew Bones, Interim Chief Financial Officer, will host an in-person briefing for analysts at 11:00am GMT on the day of the results at 85 Gresham Street, London, EC2V 7NQ. There will also be a live webcast and conference call with a Q&A session.

 

For more details or to attend the briefing, please contact optimahealth@icrinc.com

 

Enquiries

 

Optima Health

Jonathan Thomas, CEO

Andrew Bones, Interim CFO

 

+44(0) 33 0008 5113

media@OptimaHealth.co.uk

Nominated Adviser and Joint Corporate Broker

Panmure Liberum Limited

Emma Earl / Will Goode/ Mark Rogers /

Rupert Dearden

 

 

+44 (0)20 3100 2000

Joint Corporate Broker

Cavendish Capital Markets

Geoff Nash / Ben Jeynes / George Lawson /

Julian Morse / Michael Johnson/ Nigel Birks

 

+ 44 (0)20 7220 0500

 

UK Financial PR Adviser

ICR Healthcare

Mary-Jane Elliott / Chris Welsh / Lindsey Neville

optimahealth@icrinc.com

 

 

 

About Optima Health

Optima Health is the UK’s leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 2,000 including 1,250 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.

 

In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.

 

For more information visit www.optimahealth.co.uk  

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORFIFVRLRLALIR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read